PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:05 AM ET

Sponsor Check › Person

DP
No photo found yet (own website and image search run after this page is viewed)

Deepa Pakianathan

Named as an officer, director or promoter on SEC Form D filings · CA · May 3, 2010 → Jul 31, 2014

3deals (issuers)
$119.5Mreported sold
35investors
11Form D filings
2010–2014years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:21 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Deepa Pakianathan is listed as a director on 11 SEC Form D filings by 3 issuers between May 2010 and Jul 2014: Relypsa Inc (Santa Clara, CA — pharmaceuticals — 2010–2012; $70.1M reported sold to 15 investors), Calithera Biosciences, Inc. (South San Francisco, CA — biotechnology — 2011–2014; $27.1M reported sold to 19 investors) and OncoMed Pharmaceuticals Inc (Redwood City, CA — biotechnology — 2013; $22.2M reported sold to 1 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $119.5M sold in total.

Listed alongside Gerrit Klaerner (6 shared filings), Jerry M. Buysse (6 shared filings), Ronald Krasnow (6 shared filings), Scott Rocklage (6 shared filings), Jean George (4 shared filings) and 31 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Deepa. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 11 public filings for Deepa Pakianathan and found 11 differences, 1 worth asking the sponsor about: Deepa Pakianathan is no longer listed on the Dec 11, 2012 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Deepa Pakianathan has not run yet — it is joining a line of 6,288 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:21 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Deepa Pakianathan..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:21 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Deepa Pakianathan — 1 worth asking about (compared 11 filings on Oct 24, 2026)

Worth asking · Oct 5, 2012 – Dec 11, 2012

Deepa Pakianathan is no longer listed on the Dec 11, 2012 amendment — Relypsa Inc

Deepa Pakianathan appears on the Oct 5, 2012 Form D/A (director) but not on the Dec 11, 2012 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Jul 1, 2014 – Jul 31, 2014

Form D filed 30 days after the first sale — Calithera Biosciences, Inc.

The filing says the first sale was Jul 1, 2014. The Form D was filed Jul 31, 2014 — 30 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 15 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · May 3, 2010 – Jul 30, 2010

Offering amount changed between filings — Relypsa Inc

The May 3, 2010 filing says $4,000,040 offered; the Jul 30, 2010 Form D/A says $6,000,060.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jul 1, 2014 – Jul 31, 2014

No amendment in the last 12 months on an offering that may still be open — Calithera Biosciences, Inc. (latest filing Jul 31, 2014)

The latest filing for this offering is dated Jul 31, 2014 (first sale Jul 1, 2014). It reports $15,999,998 sold of $29,999,999 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Dec 19, 2012 – Dec 31, 2012

No amendment in the last 12 months on an offering that may still be open — Calithera Biosciences, Inc. (latest filing Dec 31, 2012)

The latest filing for this offering is dated Dec 31, 2012 (first sale Dec 19, 2012). It reports $1,999,999 sold of $10,700,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Nov 7, 2011 – May 31, 2012

No amendment in the last 12 months on an offering that may still be open — Calithera Biosciences, Inc. (latest filing May 31, 2012)

The latest filing for this offering is dated May 31, 2012 (first sale Nov 7, 2011). It reports $7,999,999 sold of $31,501,060 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · May 3, 2010 – Aug 10, 2012

Industry group changed between filings — Relypsa Inc

"Biotechnology" (May 3, 2010 to Aug 8, 2011); then "Pharmaceuticals" (Aug 10, 2012 to Dec 11, 2012).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Dec 22, 2009 – Feb 12, 2013

Same name, different state: "Deepa Pakianathan" (NJ) is a separate record

This page covers filings where the address state is CA. A separate record, "Deepa Pakianathan" with address state NJ, is listed on 3 filings — most recently by PTC THERAPEUTICS, INC. (Feb 12, 2013). Both records have filings in the same period (May 3, 2010 to Feb 12, 2013).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Mar 16, 2010 – May 1, 2012

Same name, different state: "Deepa Pakianathan" (A6) is a separate record

This page covers filings where the address state is CA. A separate record, "Deepa Pakianathan" with address state A6, is listed on 2 filings — most recently by NeurAxon(USA), Inc. (May 1, 2012). Both records have filings in the same period (May 3, 2010 to May 1, 2012).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Dec 31, 2012 – Jul 31, 2014

Address moved from Menlo Park, CA to South San Francisco, CA — Calithera Biosciences, Inc.

The people listed on the Dec 31, 2012 filing give Menlo Park, CA; on the Jul 31, 2014 filing they give South San Francisco, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · May 3, 2010 – Jul 30, 2010

Minimum investment changed between filings — Relypsa Inc

The May 3, 2010 filing lists a minimum of $3,000; the Jul 30, 2010 Form D/A lists $1,600.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 7 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 31, 2014 D
Calithera Biosciences, Inc.
File 021-222059
$0$0$0None listed on this filingEDGAR ↗
Dec 6, 2013 D
OncoMed Pharmaceuticals Inc
File 021-207569
$0$0$0None listed on this filingEDGAR ↗
Dec 31, 2012 D
Calithera Biosciences, Inc.
File 021-189151
$0$0$0None listed on this filingEDGAR ↗
Oct 5, 2012 D/A
Relypsa Inc
File 021-182532
$0$0$0None listed on this filingEDGAR ↗
May 31, 2012 D/A
Calithera Biosciences, Inc.
File 021-168501
$0$0$0None listed on this filingEDGAR ↗
Aug 8, 2011 D/A
Relypsa Inc
File 021-147705
$0$0$0None listed on this filingEDGAR ↗
Jul 30, 2010 D/A
Relypsa Inc
File 021-141429
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Deepa Pakianathan on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Calithera Biosciences, Inc.

South San Francisco, CA · Nov 10, 2011 → Jul 31, 2014 · 4 filings
  • Jul 31, 2014 · D · $15,999,998 sold of $29,999,999 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 31, 2012 · D · $1,999,999 sold of $10,700,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2012 · D/A · $7,999,999 sold of $31,501,060 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 10, 2011 · D · $3,999,999 sold of $31,501,060 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $27.1M from 19 investors (91% of the $30M target) as of the latest filing. Deepa is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

OncoMed Pharmaceuticals Inc

Redwood City, CA · Dec 6, 2013
  • Dec 6, 2013 · D · $22,249,996 sold of $22,249,996 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $22.2M from 1 investor (100% of the $22.2M target) as of the latest filing. Deepa is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(c) (163 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Relypsa Inc

Santa Clara, CA · May 3, 2010 → Oct 5, 2012 · 6 filings
  • Oct 5, 2012 · D/A · $62,412,304 sold of $80,000,200 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 10, 2012 · D · $49,677,652 sold of $80,000,200 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 8, 2011 · D/A · $70,129,747 sold of $70,129,747 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 14, 2010 · D · $35,129,747 sold of $70,129,747 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 30, 2010 · D/A · $6,000,060 sold of $6,000,060 · 11 investors · min. $1,600 · role: Director EDGAR ↗
  • May 3, 2010 · D · $4,000,040 sold of $4,000,040 · 11 investors · min. $3,000 · role: Director EDGAR ↗

Raised $70.1M from 15 investors (88% of the $80M target) as of the latest filing. Deepa is listed as director on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Deepa Pakianathan — NJ, 1 issuer, Dec 22, 2009 → Feb 12, 2013 · no shared issuer
  • Deepa Pakianathan — Ontario, Canada (as filed: A6), 1 issuer, Mar 16, 2010 → May 1, 2012 · no shared issuer

People around Deepa 36

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Rocklage

Director · 6 shared filings (1 issuer) · also on 17 other issuers

Scott Rocklage is on 18 issuers in total — a repeat sponsor. Their page lists every one.

GK
No photo found yet (own website and image search run after this page is viewed)
Person

Gerrit Klaerner

Executive Officer, Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jerry M. Buysse

Executive Officer · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald Krasnow

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan T. Silverstein

Director · 4 shared filings (1 issuer) · also on 32 other issuers

Jonathan T. Silverstein is on 33 issuers in total — a repeat sponsor. Their page lists every one.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jean George

Director · 4 shared filings (1 issuer) · also on 11 other issuers

Jean George is on 12 issuers in total — a repeat sponsor. Their page lists every one.

VL
No photo found yet (own website and image search run after this page is viewed)
Person

Vijay Lathi

Director · 4 shared filings (1 issuer) · also on 13 other issuers

Vijay Lathi is on 14 issuers in total — a repeat sponsor. Their page lists every one.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Schuetz

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Susan Molineaux

Executive Officer, Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Ralph Christoffersen

Director · 4 shared filings (1 issuer) · also on 6 other issuers

Ralph Christoffersen is on 7 issuers in total — a repeat sponsor. Their page lists every one.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Janis Naeve

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

KV
No photo found yet (own website and image search run after this page is viewed)
Person

Klaus Veitinger

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jay P. Shepard

Director · 2 shared filings (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Laurence Lasky

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Ron Hunt

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

LB
No photo found yet (own website and image search run after this page is viewed)
Person

Lance Berman

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

Wilhelm Stahl

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

CL
No photo found yet (own website and image search run after this page is viewed)
Person

Claire Lockey

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

WW
No photo found yet (own website and image search run after this page is viewed)
Person

William D. Waddill

Executive Officer · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Root

Director · 1 shared filing (1 issuer) · also on 18 other issuers

Jonathan Root is on 19 issuers in total — a repeat sponsor. Their page lists every one.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Lasersohn

Director · 1 shared filing (1 issuer) · also on 7 other issuers

Jack Lasersohn is on 8 issuers in total — a repeat sponsor. Their page lists every one.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

Denise Pollard-Knight

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

PH
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Hastings

Executive Officer, Director · 1 shared filing (1 issuer) · also on 4 other issuers

Paul Hastings is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Woody

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JJ
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Johnson

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jakob Dupont

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

TH
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Hoey

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Austin Gurney

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

John A. Lewicki

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Larry Lasky

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Wyzga

Director · 1 shared filing (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Sunil Patel

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Alicia J. Hager

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Drachman

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Deepa Pakianathan. Their page shows their other deals.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Terry Gould

Director · 1 shared filing (1 issuer) · also on 10 other issuers

Terry Gould is on 11 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Broderick

Director · 1 shared filing (1 issuer) · also on 6 other issuers

James Broderick is on 7 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Same business address

2 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Deepa Pakianathan by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Deepa Pakianathan is listed on: none on file. No website or social profile named in OncoMed Pharmaceuticals Inc's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #324,629 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Redwood City, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Deepa Pakianathan appears on a new Form D, or when a court case or SEC action is matched to them. See plans →